Novel bUT-B2 urea transporter isoform is constitutively activated
P Tickle1, A Thistlethwaite, C P Smith
1Faculty of Life Sciences, The University of Manchester, Manchester, UK.
Summary
This study characterizes the novel bUT-B2 urea transporter, finding it mediates significant urea flux unaffected by vasopressin or common signaling pathways. Glycosylation may regulate its constitutive activity.
Area of Science:
- Physiology
- Molecular Biology
- Membrane Transport
Background:
- The UT-B urea transporter family includes novel isoforms like bUT-B2.
- Functional characterization of bUT-B2 and its orthologs is largely undefined.
- Understanding urea transporter function is crucial for kidney physiology.
Purpose of the Study:
- To functionally characterize the bUT-B2 urea transporter.
- To investigate the regulation of bUT-B2-mediated urea transport.
- To determine the effect of vasopressin and other signaling molecules on bUT-B2 activity.
Main Methods:
- Stable expression of bUT-B2 in MDCK cells.
- Measurement of transepithelial urea flux across cell monolayers.
- Inhibition studies using known urea transporter blockers.
- Investigation of vasopressin, cAMP, calcium, and protein kinase effects.
Main Results:
- bUT-B2 mediated a significant basal transepithelial urea flux.
- Urea transport was inhibited by 1,3 dimethylurea, thionicotinamide, and phloretin.
- Vasopressin, altered intracellular cAMP, calcium, or protein kinase activity did not affect bUT-B2 function.
- Immunoblot data suggested a role for glycosylation in bUT-B2 regulation.
Conclusions:
- bUT-B2 exhibits constitutively active transepithelial urea transport.
- bUT-B2 function is independent of vasopressin and common signaling pathways.
- Glycosylation is a potential regulatory mechanism for bUT-B2.
Related Concept Videos
01:23Urea Cycle
The urea cycle describes how liver cells convert ammonia to urea. Ammonia is a toxic waste product of protein catabolism. Land animals must convert ammonia into the less toxic urea which can be safely eliminated by the kidneys through urine. Marine animals excrete ammonia directly, and the surrounding water dilutes the ammonia to safe levels.
01:15Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
01:28Renal Drug Excretion: Tubular Secretion
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
01:17Pore Transport and Ion-Pair Transport
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
01:06Carrier-Mediated Transport
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
01:30ATP Driven Pumps III: V-type Pumps
V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...